International News

Home » International News

Beacon Medicare Limited joined AORTIC’s conference on cancer in Mozambique

Beacon Medicare Limited, pioneer of oncology products manufacturer and one of the leading and fastest growing pharmaceutical companies in Bangladesh, participated in the AORTIC’s international conference on cancer in Mozambique last year. The 12th AORTIC conference was held with the theme Cancer in Africa: Innovation, Strategies and Implementation, in Maputo, the capital and most populous [...]

By |2020-10-14T05:22:58+00:00October 14th, 2020|International News|0 Comments

Beacons Presence in Conference on Liver Disease in Africa (COLDA) at Kenya

Beacon Medicare Ltd. has attended in the Kenya Liver Disease Conference of Kenya, held in Nairobi from 13th to 15th September, 2018. More than thousand doctors around the African community have attended in the conference. Beacon was one of the key sponsors for this event. Beacon is pioneer in producing generic lifesaving hepatitis drugs. African [...]

By |2020-09-28T03:31:16+00:00September 23rd, 2019|International News|0 Comments

Annual Conf. 2018- Nepal Team held in head office of Beacon

Beacon team holds the No.1 position among oncology companies of Nepal. Team Nepal is a role model of marketing for Beacon Medicare Ltd. The Nepal team shared their success of 2018 and strategies for 2019 in the conference which was held in Beacon Business center, Dhaka, Bangladesh. The team celebrated their achievement in Bangkok, Thailand. [...]

By |2020-09-28T03:31:16+00:00September 22nd, 2019|International News|0 Comments

Annual Business Conference of BEACON Medicare Limited 2017 held in Istanbul,Turkey

In 29th December, 2017 the annual conference of BEACON Medicare Limited held in Istanbul, Turkey. Chairman of Beacon Group Md. Ebadul Karim, Managing Director Niazul karim , Executive Vice President Monjurul Alam, Sr.Manager Md.Sahariar Tamal Selim and all the Global business executives were present there. In this conference Managing Director Niazul Karim declared that "considering the huge [...]

By |2020-09-28T03:31:16+00:00July 3rd, 2019|International News|0 Comments

The BDD team of BEACON held Annual Conference in Bali, Indonesia

The Annual conference of Business Development Department of BEACON Pharmaceuticals Limited (BPL) was held in Bali, Indonesia on 31st December, 2016 The conference theme was “Caring Globally”. In the opening speech the Managing Director of BEACON, Md. Ebadul Karim advised BDD members to work hard to make BEACON’s product available to global patients specially who [...]

By |2020-09-28T03:31:18+00:00January 16th, 2017|International News|0 Comments

45 Countries Under Beacon Pharmaceuticals Hep C Support Program

Like-wise number one in Oncology, Beacon Pharmaceuticals Limited is the first company in Bangladesh who is proudly exporting Hepatitis C generic medicine more than 45 countries around the Globe. Under the patient support program Beacon Pharmaceuticals Limited can deliver their generic medicine to everyone everywhere around the world. The countries under the coverage of BEACON [...]

By |2020-09-28T03:31:19+00:00March 31st, 2016|International News|Comments Off on 45 Countries Under Beacon Pharmaceuticals Hep C Support Program

Two More General Products (Prasugrel) Received Registration in Myanmar

Beacon Pharmaceutical has received registration of two more products Prasugrel 5 and 10 in Myanmar. Prasugrel is used for prevent thrombosis (blood clotting). It acts as a platelet inhibitor. Besides Prasugrel, Beacon has registered 20 Products in Myanmar. Azithromycin 500 mg Injection (Brand: Simpli-3) Baclofen 10 mg Tablet (Brand: Flexibac) Iron (100 mg elemental iron) [...]

By |2016-05-07T09:12:31+00:00March 30th, 2016|International News|Comments Off on Two More General Products (Prasugrel) Received Registration in Myanmar

Annual Sales Conference of Beacon’s Nepal Oncology Team Held at Cox’s Bazar

Beacon Pharmaceutical and their Nepal partner, Prime Care International Pvt. Ltd have jointly organized the Annual sales conference 2015 at Cox’s Bazar, Bangladesh. Directors of Prime Oncology Manager of Beacon Oncology, Nepal and Hi-officials of Business Development Dept. were present in the Conference. Performance of 2015 and budget and planning for 2016 were discussed in [...]

By |2016-05-07T09:22:27+00:00March 30th, 2016|International News|Comments Off on Annual Sales Conference of Beacon’s Nepal Oncology Team Held at Cox’s Bazar

Beacon Organizes Seminar on Targeted Cancer Therapy in Sri Lanka

Beacon Pharmaceuticals limited and their Sri Lanka partner, Emerchemie has organized a seminar on targeted cancer Therapy at Hotel Cinnamon Lake Colombo. Dr. Foo Sr. consultant oncology Mount Elizabeth Hospital, Singapore was the key note speaker in the seminar. Dr. Foo has expressed his satisfaction of clinical success by using erlotinib in lung cancer, sunitinib [...]

By |2016-05-07T10:38:16+00:00March 30th, 2016|International News|Comments Off on Beacon Organizes Seminar on Targeted Cancer Therapy in Sri Lanka

BEACON introduce global first generic Daclatasvir INN 60 mg tablet

Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce. Daclavir (Daclatasvir) should be combined with other medications, which may include other direct-acting [...]

By |2016-03-21T07:50:59+00:00March 19th, 2016|International News|Comments Off on BEACON introduce global first generic Daclatasvir INN 60 mg tablet